IL6 and congenital rubella syndrome: IL-6 is a crucial cytokine in the pathogenesis of hyperinflamed critically ill patients with sepsis, COVID-19, and the cytokine release syndrome (CRS) that a proportion of patients develop after receiving CAR-T cell therapy [105, 106].